Adi Barzilay Spruijt
About Adi Barzilay Spruijt
Adi Barzilay Spruijt is a Quality Assurance Manager EU at Kite Pharma, with a background in quality assurance and production in the pharmaceutical industry. He has held various roles at Sanquin and Teva Pharmaceutical Industries, and he holds a Bachelor's degree in International Business and a Master's degree in Industrial Pharmacy.
Current Role at Kite Pharma
Adi Barzilay Spruijt serves as the Quality Assurance Manager EU at Kite Pharma, a position held since 2021. In this role, he is responsible for overseeing quality assurance processes and ensuring compliance with regulatory standards within the European operations of the company. His work is based in Hoofddorp, North Holland, Netherlands.
Previous Experience in Quality Assurance
Prior to his current role, Adi Barzilay Spruijt worked at Sanquin as a Quality Officer from 2014 to 2017, where he gained significant experience in quality management within the healthcare sector. He also held the position of Senior Quality Assurance Officer at Sanquin in 2018 for eight months, further enhancing his expertise in quality assurance practices.
Experience at Teva Pharmaceutical Industries Ltd.
Adi Barzilay Spruijt began his career in the pharmaceutical industry at Teva Pharmaceutical Industries Ltd. He worked as an Operator from 2011 to 2013 and later as a Production Assistant from 2013 to 2014. His roles at Teva provided him with foundational knowledge in production processes and quality control.
Educational Background
Adi Barzilay Spruijt holds a Bachelor's Degree in International Business from the International Business School at Amsterdam University of Applied Sciences, which he completed from 2013 to 2016. He further advanced his education by obtaining a Master's degree in Industrial Pharmacy from The University of Manchester, studying from 2016 to 2021.
Career Progression in Quality Assurance
After his initial experience at Sanquin, Adi Barzilay Spruijt transitioned to Kite Pharma, where he served as a Senior QA Specialist from 2018 to 2021. This role allowed him to develop his skills in quality assurance before advancing to his current managerial position. His career reflects a consistent focus on quality assurance within the pharmaceutical industry.